Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9273986 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus
Conditions: Cytomegalovirus Infections;   Inflammatory Bowel Diseases
Intervention: Drug: Valganciclovir

Indicates status has not been verified in more than two years